Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For ABG
Valuation Weak
28%
Profitability n.A.
Fin. Growth Positive
67%
Leverage & Liquidity Weak
33%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -0.30 1.06 1.06
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -7.66 17.63 19.10
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 3.68 164.87 159.02
Cash -30.49 1.77 2.54
Capex -60.36 -5.17 -3.23
Free Cash Flow 737.89 3.04 0.36
Revenue 10.76 206.95 186.85
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 1.16 0.17 0.17
Operating Margin -1.46 0.06 0.06
ROA 165.77 0.01 < 0.005
ROE 156.90 0.04 0.02
ROIC 10.91 0.02 0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of ABG is permitted for members.
5 Growth
The "Growth Entry" for the Focus of ABG is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of ABG is permitted for members.